...
首页> 外文期刊>Canadian journal of anesthesia: Journal canadien d'anesthesie >Renin-angiotensin blockade is associated with increased mortality after vascular surgery.
【24h】

Renin-angiotensin blockade is associated with increased mortality after vascular surgery.

机译:肾素-血管紧张素阻断与血管手术后死亡率增加相关。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: The outcome of patients with preoperative renin-angiotensin system (RAS) blockade, achieved either by angiotensin converting enzyme inhibitors or angiotensin receptor blocking agents, was assessed using 30-day mortality as a primary end point. METHODS: An observational cohort study of 883 consecutive patients undergoing elective open abdominal aortic aneurysm repair (AAA) was undertaken and analyzed using a propensity score matched study. The data collected included medical history, anesthetic techniques, and postoperative outcomes. Logistic regression analysis identified predictors of RAS blockade: hypertension, stroke, congestive heart failure, diabetes, and heart disease. A propensity score for RAS blockade was calculated for each subject using several factors: age, sex, serum creatinine, hypertension, heart disease, congestive heart failure, stroke, diabetes, and exposure to cardiovascular medications. Subjects and controls were matched using the calculated propensity score. RESULTS: The overall 30-day mortality rate was 3.5% (31/883 patients). The crude mortality rate in RAS blocked patients was 5.8% (21/359) vs 1.9% (10/524) in unexposed patients (odds ratio 3.2, with 95% confidence intervals [CI(95)] 1.5-6.7; P < 0.001). Analysis of 261 propensity score matched pairs showed a 30-day mortality rate of 6.1% (16/261) in the RAS blocked group vs 1.5% (4/261) in unblocked patients (P = 0.008). The estimated odds ratio for 30-day mortality associated with RAS blockade was 5.0 (CI(95) 1.4-27). CONCLUSIONS: Examination of 883 cases of AAA repair showed increased mortality associated with preoperative RAS blockade. A better understanding of perioperative pharmacology and physiology of RAS blockade is needed as well as future studies to identify causality.
机译:目的:采用30天死亡率作为主要终点,评估通过血管紧张素转化酶抑制剂或血管紧张素受体阻断剂实现的术前肾素-血管紧张素系统(RAS)阻断患者的结局。方法:进行了一项观察性队列研究,该研究连续进行了883例接受择期开放性腹主动脉瘤修复(AAA)的患者,并使用倾向评分匹配研究进行了分析。收集的数据包括病史,麻醉技术和术后结果。 Logistic回归分析确定了RAS阻滞的预测因素:高血压,中风,充血性心力衰竭,糖尿病和心脏病。使用几项因素计算出每个受试者的RAS阻滞倾向得分:年龄,性别,血清肌酐,高血压,心脏病,充血性心力衰竭,中风,糖尿病和接触心血管药物。使用计算出的倾向得分对受试者和对照进行匹配。结果:30天总死亡率为3.5%(31/883名患者)。 RAS受阻患者的粗死亡率为5.8%(21/359),而未暴露患者的粗死亡率为1.9%(10/524)(优势比3.2,95%置信区间[CI(95)] 1.5-6.7; P <0.001) )。对261个倾向得分匹配对的分析显示,RAS阻断组的30天死亡率为6.1%(16/261),而未阻断患者的30天死亡率为1.5%(4/261)(P = 0.008)。与RAS封锁相关的30天死亡率的估计优势比为5.0(CI(95)1.4-27)。结论:883例AAA修复检查显示,术前RAS阻断相关的死亡率增加。需要对围手术期RAS阻断的药理学和生理学有更好的了解,并需要进一步的研究来确定因果关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号